Intellia Therapeutics (NTLA) Tops Q3 EPS by 13c, Revenues Beat

October 31, 2019 7:46 AM

Intellia Therapeutics (NASDAQ: NTLA) reported Q3 EPS of ($0.49), $0.13 better than the analyst estimate of ($0.62). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found